Academic Journal
Can we improve the treatment of congestion in heart failure?
| العنوان: | Can we improve the treatment of congestion in heart failure? |
|---|---|
| المؤلفون: | METRA, Marco, BETTARI, Luca, CARUBELLI, Valentina, LAZZARINI, Valentina, LOMBARDI, Carlo Mario, DEI CAS, Livio, Bugatti S, Danesi R |
| المساهمون: | Metra Marco, Bugatti S, Bettari Luca, Carubelli Valentina, Danesi R, Lazzarini Valentina, Lombardi Carlo Mario, DEI CAS Livio |
| سنة النشر: | 2011 |
| المجموعة: | Università degli Studi di Brescia: OPENBS - Open Archive UniBS |
| مصطلحات موضوعية: | Congestion, acute heart failure, diuretics |
| الوصف: | INTRODUCTION: Dyspnoea and peripheral oedema, caused by fluid redistribution to the lungs and/or by fluid overload, are the main causes of hospitalization in patients with heart failure and are associated with poor outcomes. Treatment of fluid overload should relieve symptoms and have a neutral or favorable effect on outcomes. AREAS COVERED: We first consider the results obtained with furosemide administration, which is still the mainstay of treatment of congestion in patients with heart failure. We then discuss important shortcomings of furosemide treatment, including the development of resistance and side effects (electrolyte abnormalities, neurohormonal activation, worsening renal function), as well as the relationship of furosemide - and its doses - with patient prognosis. Finally, the results obtained with potential alternatives to furosemide treatment, including different modalities of loop diuretic administration, combined diuretic therapy, dopamine, inotropic agents, ultrafiltration, natriuretic peptides, vasopressin and adenosine antagonists, are discussed. EXPERT OPINION: Relief of congestion is a major objective of heart failure treatment but therapy remains based on the administration of furosemide, an agent that is often not effective and is associated with poor outcomes. The results of the few controlled studies aimed at the assessment of new treatments to overcome resistance to furosemide and/or to protect the kidney from its untoward effects have been mostly neutral. Better treatment of congestion in heart failure remains a major unmet need. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | STAMPA |
| اللغة: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/21342081; info:eu-repo/semantics/altIdentifier/wos/WOS:000291444500003; volume:12; issue:9; firstpage:1369; lastpage:1379; numberofpages:11; journal:EXPERT OPINION ON PHARMACOTHERAPY; http://hdl.handle.net/11379/45722; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79956160272 |
| DOI: | 10.1517/14656566.2011.557069 |
| الاتاحة: | http://hdl.handle.net/11379/45722 https://doi.org/10.1517/14656566.2011.557069 |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.64CDC750 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1517/14656566.2011.557069 |
|---|